Related Experiment Video
Updated: Mar 16, 2026
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.5K
Coagulation and non-coagulation effects of thrombin
J J N Posma1, J J Posthuma1, H M H Spronk2
1Departments of Internal Medicine and Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.
Journal of Thrombosis and Haemostasis : JTH
|August 12, 2016
Summary
Thrombin, a key protease, regulates blood clotting and non-hemostatic processes. Its dual role in inflammation, particularly in cardiovascular disease, warrants further investigation due to complex signaling pathways.
Area of Science:
- Biochemistry
- Physiology
- Molecular Biology
Background:
- Thrombin is a serine protease derived from prothrombin.
- It is crucial for both primary and secondary hemostasis.
- Thrombin also mediates non-hemostatic functions via protease-activated receptors (PARs).
Purpose of the Study:
- To review the hemostatic and non-hemostatic functions of thrombin.
- To focus on the dual, often opposing, non-hemostatic roles of thrombin.
- To explore thrombin's involvement in cardiovascular disease.
Main Methods:
- Literature review of thrombin's functions.
- Analysis of thrombin signaling pathways.
- Examination of PAR activation mechanisms.
Main Results:
- Thrombin's critical role in platelet activation and coagulation cascade.
- Diverse cellular responses mediated by thrombin through PARs.
- Thrombin exhibits paradoxical inflammatory and anti-inflammatory effects.
Conclusions:
- Thrombin's signaling complexity underlies its dual roles.
- Understanding thrombin's non-hemostatic functions is vital for cardiovascular disease research.
- Further research is needed to elucidate the precise mechanisms of thrombin's dichotomous actions.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
01:09Coagulation
11.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.6K
01:06Coagulation
1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
01:16Clot Retraction and Fibrinolysis
9.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.9K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
14.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.7K
01:24Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K